Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2010
10/13/2010CN101099738B Application of sanguinarine in preparing aquatic animal medicine and method for preparing its preparation
10/13/2010CN101081843B Non-nucleoside reverse transcriptase inhibitors
10/13/2010CN101019971B Compound Chinese medicine preparation for treating hepatitis B and its preparation process
10/13/2010CN101019869B Medicine composition of alprostadil and Chuanhuning/Yanhuning liposome and its preparation
10/12/2010US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids
10/12/2010US7812134 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
10/12/2010US7812015 Using tricyclic or tetracyclic antidepressant amitryptiline, imipramine, desipramine or FGF as inhibitors of acid sphingomyelinase which liberates ceramide, for prophylaxis and/or treatment of infectious diseases ( AIDS, hepatitis A, tuberculosis, rubella, SSME, influenza, rhinoviral diseases, malaria)
10/12/2010US7812014 such as (5R,6Z)-6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, in combination with beta-lactam antibiotics, for the treatment of bacterial infections
10/12/2010US7812009 Mastitis treatment
10/12/2010US7811818 Hepatocyte culture for use monitoring liver metabolism and diagnosing liver disorders; useful in transplantation, for experimental evaluation, and as a source of lineage and cell specific products
10/12/2010US7811599 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
10/12/2010US7811590 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system
10/12/2010US7811588 Therapeutic agent for treatment and prevention of bacterial infections; immunoassay
10/12/2010US7811585 Streptococcus pyogenes antigens
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010CA2456356C Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
10/12/2010CA2445512C A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
10/12/2010CA2438657C Testosterone-containing transdermal therapeutic system and process for its production
10/12/2010CA2427352C Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase
10/12/2010CA2416899C Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
10/12/2010CA2413699C Topical pharmaceutical formulations and methods of treatment
10/12/2010CA2383955C Extracorporeal endotoxin removal method
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/12/2010CA2376305C Sulfonamide and sulfamide substituted imidazoquinolines
10/12/2010CA2375599C Probiotic compositions comprising e. coli and volatile fractions of plant extracts
10/12/2010CA2338946C Hepatitis c inhibitor tri-peptides
10/12/2010CA2329751C Substituted porphyrins
10/12/2010CA2327528C Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
10/12/2010CA2313089C Methods for treatment of neuro- and nephro- disorders and therapeutic toxicities using aminothiol compounds
10/12/2010CA2219943C Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits
10/12/2010CA2198586C Mutant enterotoxin effective as a non-toxic oral adjuvant
10/07/2010WO2010115172A2 Antigenic peptide of hsv-2 and methods for using same
10/07/2010WO2010115130A1 Histidine derivatives and their pharmaceutical uses
10/07/2010WO2010114629A2 Formulation
10/07/2010WO2010114628A2 Formulation for inducing broadly reactive neutralizing anti-hiv antibodies
10/07/2010WO2010114533A1 Anti-biofilm carbonate compounds for use in oral care compositions
10/07/2010WO2010114106A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010114105A1 Monoclonal antibody capable of binding to ad2 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113595A1 Lactic acid bacterium fermentation product using polyphenol component and method for producing same
10/07/2010WO2010113157A1 Lipopeptide inhibitors of hiv-1
10/07/2010WO2010113151A1 Conjugated antimicrobial agents
10/07/2010WO2010112968A1 Water-soluble antiviral product containing momordica balsamina, for the treatment and prevention of acquired immunodeficiency syndrome (aids) and the variants thereof
10/07/2010WO2010112967A1 Water-soluble antiviral product containing cyperus articulatus, for the treatment and prevention of acquired immunodeficiency syndrome (aids) and the variants thereof
10/07/2010WO2010112966A1 Water-soluble antiviral product containing aframomum melegueta, for the treatment and prevention of acquired immunodeficiency syndrome (aids)
10/07/2010WO2010112874A1 Imidazo [2, 1-b] [ 1, 3, 4 ] thiadiazole derivatives
10/07/2010WO2010112656A1 Compounds stimulating undesirable cellular adhesion and applications thereof
10/07/2010WO2010112578A1 4 -isopropyl-3-methylphenol for the treatment of inflammation
10/07/2010WO2010112510A1 Use of flavonoids to increase the bioavailability of hesperetin
10/07/2010WO2010111886A1 Traditional chinese medicinal ointment for treating burn, scald and infective trauma and preparative method thereof
10/07/2010WO2010111842A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
10/07/2010WO2010093843A3 Hcv combination therapies comprising pegylated interferon, ribavirin and telaprevir
10/07/2010WO2010075861A3 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
10/07/2010WO2009106986A3 Nonstructural protein ns1 as a novel therapeutic target against flaviviruses: use of inhibiting molecules interfering with ns1 maturation or biological activity
10/07/2010US20100256576 Disinfectant Compositions, Methods and Systems
10/07/2010US20100256223 Oligonucleotides for modulating target rna activity
10/07/2010US20100256219 Small interfering DNA (siDNA) oligonucleotides as an antiviral agent against Herpes virus infections
10/07/2010US20100256217 Antiviral inhibition of casein kinase ii
10/07/2010US20100256203 Benzimidazoles and pharmaceutical compositions thereof
10/07/2010US20100256181 Non-nucleoside reverse transcriptase inhibitors
10/07/2010US20100256179 Combination therapy for pain in painful diabetic neuropathy
10/07/2010US20100256169 Administration of tlr7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus
10/07/2010US20100256143 Pharmaceutical compounds
10/07/2010US20100256139 Anti-Viral Compounds
10/07/2010US20100256138 Benzimidazole derivatives: preparation and pharmaceutical applications
10/07/2010US20100256137 Indazolamide derivatives
10/07/2010US20100256124 Substituted 1-Methyl-1H-Quinolin-2-Ones And 1-Methyl-1H-1,5-Naphthyridin-2-Ones As Antibacterials
10/07/2010US20100256120 Amide derivatives
10/07/2010US20100256118 Novel adenine compound and use thereof
10/07/2010US20100256112 Hydroxythienoquinolones and related compounds as anti-infective agents
10/07/2010US20100256110 Pharmaceutical solid dispersions
10/07/2010US20100256107 Preparation composition
10/07/2010US20100256096 Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
10/07/2010US20100256092 Boron-containing small molecules
10/07/2010US20100256088 Low dose therapy for treating viral infections
10/07/2010US20100256087 Compositions for the treatment or prophylaxis of viral infections
10/07/2010US20100256085 Toll-Like Receptor Agonist Regulation of VEGF-Induced Tissue Responses
10/07/2010US20100256081 Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
10/07/2010US20100256074 Processes for preparing high purity aza cyclohexapeptides
10/07/2010US20100256050 Composition for preventing virus infection comprising poly-gamma-glutamic acid
10/07/2010US20100256049 Macrolactone derivatives
10/07/2010US20100256048 Polypeptide compound
10/07/2010US20100256041 Conjugate Molecule Compounds With Enhanced Cell Uptake Activity
10/07/2010US20100256040 Composition and method for treating viral infection
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255130 Aloe preparation for skin enhancement
10/07/2010US20100255128 Avian feed composition
10/07/2010US20100255107 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
10/07/2010US20100255102 Sterilization of dispersions of nanoparticulate active agents with gamma radiation
10/07/2010US20100255083 Controlled-release pharmaceutical formulation and process for its preparation
10/07/2010US20100255078 Serpin drugs for treatment of viral infection and method of use thereof
10/07/2010US20100255069 Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic use of components of angelica sinensis, and methods of preparation thereof
10/07/2010US20100255040 Composition for improving tlr-mediated cellular immunity comprising poly-gamma-glutamic acid
10/07/2010US20100255038 Purified polypeptide comprising or consisting of a c-terminus msp1 antigen from plasmodium falciparum carrying a glycosyl-phosphatidyl-inositol group (gpi)
10/07/2010US20100255036 Attenuated fnr deficient enterobacteria
10/07/2010US20100255035 Modified live (JMSO strain) Haemophilus parasuis vaccine
10/07/2010US20100255033 Non-toxic double mutant forms of pertussis toxin as adjuvants
10/07/2010US20100255032 Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases
10/07/2010US20100255031 truncated l1 protein of human papillomavirus type 16
10/07/2010US20100255030 Avirulent, immunogenic flavivirus chimeras
1 ... 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 ... 1798